Hypergene provides Cancerfonden with enhanced support for planning, reporting, and analysis
Cancerfonden has taken a significant step in its efforts to streamline administrative processes through digitalisation. Over the past year, the organisation has been seeking a platform to optimise its planning and reporting functions. Previously, the manual compilation of reports for the board and management was a highly time-consuming task. Although the data quality was consistently high, the ability to perform more advanced analysis and forecasting was limited.
As part of its digitalisation journey, Cancerfonden has now chosen Hypergene. This innovative solution will offer comprehensive support for planning, forecasting, reporting, and analysis, significantly improving the efficiency of internal operations.
Cancerfonden is an independent, non-profit organisation that operates without government funding. As one of the largest financiers of cancer research in Sweden, they have distributed SEK 16 billion to leading research projects since 1951. Today, Cancerfonden receives close to SEK 1 billion annually from individuals and companies alike.
